Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain slow potentials (CNV), prolactin, and schizophrenia.

P A Rizzo, G F Albani, M Spadaro

    Biological Psychiatry
    |February 1, 1983
    PubMed
    Summary

    This study investigated contingent negative variation (CNV) in schizophrenia patients. Findings suggest CNV variations in schizophrenia are linked to illness stage, not neuroleptic treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

    Journal of neurology·2016
    Same author

    Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies.

    Leukemia·2013
    Same author

    Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.

    Neurology·2010
    Same author

    The action of dopamine on rat caudate neurones intracellularly recorded.

    Neuroscience letters·2009
    Same author

    DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice.

    Cancer gene therapy·2007
    Same author

    Drug adverse events and drop-out risk: a clinical case.

    Archives of gerontology and geriatrics·2007

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Clinical Neurophysiology

    Background:

    • Schizophrenia is a complex psychiatric disorder with debated neurophysiological underpinnings.
    • Contingent negative variation (CNV) reflects anticipatory brain activity and has been explored as a potential biomarker in psychiatric conditions.

    Purpose of the Study:

    • To explore the correlation between contingent negative variation (CNV) parameters and schizophrenia.
    • To investigate if CNV alterations in schizophrenia are influenced by neuroleptic therapy or disease progression.

    Main Methods:

    • Examined CNV in three distinct schizophrenia patient groups: acute illness (pre/post-therapy), chronic non-continuous therapy, and chronic long-term therapy.
    • Compared CNV parameters between patient groups and a control group.

    Main Results:

    • Observed distinct CNV patterns across the different schizophrenia patient cohorts.
    • Results indicated that CNV manifestations in schizophrenia appear independent of neuroleptic treatment.

    Conclusions:

    • The observed differences in cerebral bioelectric reactivity (CNV) are associated with the stage of schizophrenia evolution.
    • CNV may serve as an indicator of disease progression rather than a direct effect of pharmacological intervention in schizophrenia.

    Related Experiment Videos